Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Inari Medical Inc (NQ: NARI ) 49.72 +0.79 (+1.61%) Streaming Delayed Price Updated: 3:14 PM EST, Nov 5, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Inari Medical Inc < Previous 1 2 3 4 5 6 7 8 9 10 Next > PEERLESS Results Show Superiority of FlowTriever® Compared to Catheter-Directed Thrombolytics for Intermediate-Risk Pulmonary Embolism October 29, 2024 Primary endpoint win driven by both hard clinical outcomes and hospital resource utilization From Inari Medical, Inc. Via GlobeNewswire Corning Posts Upbeat Q3 Earnings, Joins Opera, Inari Medical, Incyte And Other Big Stocks Moving Higher On Tuesday October 29, 2024 Via Benzinga Key Takeaways From Inari Medical Analyst Ratings October 29, 2024 Via Benzinga Inari Medical Reports Third Quarter 2024 Financial Results October 28, 2024 From Inari Medical, Inc. Via GlobeNewswire Inari Medical's Earnings: A Preview October 25, 2024 Via Benzinga Breaking Down Inari Medical: 9 Analysts Share Their Views October 09, 2024 Via Benzinga Inari Medical Announces Partnership with AVF and NBCA on DEFIANCE Trial October 15, 2024 From Inari Medical, Inc. Via GlobeNewswire Inari Medical to Host Analyst and Investor Meeting Following PEERLESS RCT Presentation October 07, 2024 From Inari Medical, Inc. Via GlobeNewswire Inari Medical to Announce Third Quarter 2024 Financial Results October 07, 2024 From Inari Medical, Inc. Via GlobeNewswire Expert Outlook: Inari Medical Through The Eyes Of 9 Analysts September 17, 2024 Via Benzinga Breaking Down Inari Medical: 7 Analysts Share Their Views August 26, 2024 Via Benzinga Deep Dive Into Inari Medical Stock: Analyst Perspectives (5 Ratings) July 16, 2024 Via Benzinga Kaskela Law LLC Announces Shareholder Investigation of Inari Medical, Inc. (NASDAQ: NARI) and Encourages Investors to Contact the Firm September 17, 2024 From Kaskela Law LLC Via Business Wire Inari Medical Announces PEERLESS Data to be Presented During the Late-Breaking Clinical Trial Sessions at TCT 2024 August 29, 2024 From Inari Medical, Inc. Via GlobeNewswire FDA Classifies Recall Of Inari Medical's Large Vessel Clot Removal Catheter Device As Most Serious August 26, 2024 The FDA labels Inari Medical's ClotTriever catheter recall as the most serious, citing risks like device entrapment and pulmonary emboli, linked to injuries and deaths. Via Benzinga Exposures Product Safety Inari Medical to Present at Upcoming Investor Conferences August 21, 2024 From Inari Medical, Inc. Via GlobeNewswire 7 Leading MedTech Stocks for Next-Gen Health Solutions July 31, 2024 With healthcare innovations promising to deliver groundbreaking solutions, these MedTech stocks should be on your radar. Via InvestorPlace NARI Stock Earnings: Inari Medical Misses EPS, Beats Revenue for Q2 2024 July 30, 2024 NARI stock results show that Inari Medical missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. Via InvestorPlace Inari Medical Announces Chief Financial Officer Retirement and Succession Plan July 30, 2024 Mitch Hill to retire as Chief Financial Officer, to be succeeded by Kevin Strange in October 2024 From Inari Medical, Inc. Via GlobeNewswire Inari Medical Reports Second Quarter 2024 Financial Results July 30, 2024 From Inari Medical, Inc. Via GlobeNewswire Inari Medical to Announce Second Quarter 2024 Financial Results July 16, 2024 From Inari Medical, Inc. Via GlobeNewswire DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inari July 12, 2024 Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inari To Contact Him Directly To Discuss Their Options From Faruqi & Faruqi LLP Via GlobeNewswire NARI Investors Have Opportunity to Lead Inari Medical, Inc. Securities Fraud Lawsuit with the Schall Law Firm July 12, 2024 From Schall Law Via GlobeNewswire The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Inari Medical, Inc. (NARI) July 11, 2024 From The Law Offices of Frank R. Cruz Via Business Wire NARI Investors Have Opportunity to Lead Inari Medical, Inc. Securities Fraud Lawsuit with the Schall Law Firm July 11, 2024 From The Schall Law Firm Via Business Wire NARI Investors Have the Opportunity to Lead Inari Medical, Inc. Securities Fraud Lawsuit with the Schall Law Firm July 10, 2024 From The Schall Law Firm Via Business Wire INARI MEDICAL 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Inari Medical, Inc. - NARI July 09, 2024 From Kahn Swick & Foti, LLC Via Business Wire NARI Investors Have Opportunity to Lead Inari Medical, Inc. Securities Fraud Lawsuit with the Schall Law Firm July 09, 2024 From Schall Law Via GlobeNewswire NARI Investors Have the Opportunity to Lead Inari Medical, Inc. Securities Fraud Lawsuit with the Schall Law Firm July 08, 2024 From The Schall Law Firm Via Business Wire Inari Medical, Inc. INVESTOR ALERT: Kirby McInerney LLP Alerts Inari Medical, Inc. Investors of Looming Lead Plaintiff Deadline in Class Action Lawsuit July 05, 2024 From Kirby McInerney LLP Via Business Wire < Previous 1 2 3 4 5 6 7 8 9 10 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
